Racial/Ethnic and Gender Disparities in Heart Failure with Reduced Ejection Fraction

Hunter Mwansa, Sabra Lewsey, Sula Mazimba, Khadijah Breathett

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations

Abstract

Purpose of Review: This review highlights variability in prescribing of nonpharmacologic heart failure with reduced ejection fraction (HFrEF) therapies by race, ethnicity, and gender. The review also explores the evidence underlying these inequalities as well as potential mitigation strategies. Recent Findings: There have been major advances in HF therapies that have led to improved overall survival of HF patients. However, racial and ethnic groups of color and women have not received equitable access to these therapies. Summary: Patients of color and women are less likely to receive nonpharmacologic therapies for HFrEF than White patients and men. Therapies including exercise rehabilitation, percutaneous transcatheter mitral valve repair, cardiac resynchronization therapy, heart transplant, and ventricular assist devices all have proven efficacy in patients of color and women but remain underprescribed. Outcomes with most nonpharmacologic therapy are similar or better among patients of color and women than White patients and men. System-level changes are urgently needed to achieve equity in access to nonpharmacologic HFrEF therapies by race, ethnicity, and gender.

Original languageEnglish (US)
Pages (from-to)41-51
Number of pages11
JournalCurrent Heart Failure Reports
Volume18
Issue number2
DOIs
StatePublished - Apr 2021
Externally publishedYes

Keywords

  • Ethnicity
  • Health disparities
  • Heart failure
  • Outcomes
  • Race
  • Women’s health

ASJC Scopus subject areas

  • Emergency Medicine
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Fingerprint

Dive into the research topics of 'Racial/Ethnic and Gender Disparities in Heart Failure with Reduced Ejection Fraction'. Together they form a unique fingerprint.

Cite this